Trading Symbol: N/A
CUSIP Number: N/A
TERMS OF THE SETTLEMENT: The Settlement consists of $1,000,000 in cash and will include interest on the Settlement Fund prior to distribution.
CLASS DESCRIPTION: All persons who purchased the publicly-traded common stock of Northwest Biotherapeutics, Inc. traded on the U.S. and/or London markets during the period from April 17, 2007 through July 18, 2007, inclusive.
IMPORTANT DATES:
DATE TO SEEK EXCLUSION
FROM THE CLASS: MAY 16, 2009
DATE FOR SUBMISSION OF
PROOF OF CLAIM FORMS: JULY 16, 2009
TO OBTAIN A PROOF OF CLAIM FORM:
Robert M. Roseman, Esquire
SPECTOR, ROSEMAN KODROFF & WILLIS, P.C.
Tel: 215-496-0300
Fax: 215-496-6611
Email: rroseman@srkw-law.com
Keine Kommentare:
Kommentar veröffentlichen